[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fJBUgBk1F9OMXMQ4R92lljg2h0jv_w9TJHpWqPFAIwv8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":40,"rows":47},"Craig Hospital",[4],35,false,9,1,5962,3,29,[14,17,20,23,25,27,30,32],{"name":15,"count":16},"Spinal Cord Injuries",13,{"name":18,"count":19},"Traumatic Brain Injury",8,{"name":21,"count":22},"Spinal Cord Injury",6,{"name":24,"count":11},"Pain",{"name":26,"count":11},"Endothelial Dysfunction",{"name":28,"count":29},"Osteoporosis",2,{"name":31,"count":29},"Cervical Spinal Cord Injury",{"name":33,"count":29},"Tetraplegia",[35],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT06443151","Role of Endothelial Function in SCI CVD Risk","2027-03-30","Acetylcholine",[41,42,43,44,45,46],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[48,73,91,109,134,161,187,211],{"intervention":39,"totalTrials":9,"cells":49},{"EARLY_PHASE1":50,"PHASE1":53,"PHASE2":55,"PHASE3":57,"PHASE4":59,"NA":61},{"trials":51,"activeCount":52},[],0,{"trials":54,"activeCount":52},[],{"trials":56,"activeCount":52},[],{"trials":58,"activeCount":52},[],{"trials":60,"activeCount":52},[],{"trials":62,"activeCount":9,"soonestReadout":38},[63],{"nctId":36,"briefTitle":37,"status":64,"phases":65,"primaryCompletion":38,"completion":38,"start":66,"enrollment":67,"conditions":68,"interventions":70},"RECRUITING",[],"2024-09-01",60,[15,69,26],"Cardiovascular Diseases",[39,71,72],"Sodium Nitroprusside","Ascorbic acid",{"intervention":71,"totalTrials":9,"cells":74},{"EARLY_PHASE1":75,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":85},{"trials":76,"activeCount":52},[],{"trials":78,"activeCount":52},[],{"trials":80,"activeCount":52},[],{"trials":82,"activeCount":52},[],{"trials":84,"activeCount":52},[],{"trials":86,"activeCount":9,"soonestReadout":38},[87],{"nctId":36,"briefTitle":37,"status":64,"phases":88,"primaryCompletion":38,"completion":38,"start":66,"enrollment":67,"conditions":89,"interventions":90},[],[15,69,26],[39,71,72],{"intervention":72,"totalTrials":9,"cells":92},{"EARLY_PHASE1":93,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":101,"NA":103},{"trials":94,"activeCount":52},[],{"trials":96,"activeCount":52},[],{"trials":98,"activeCount":52},[],{"trials":100,"activeCount":52},[],{"trials":102,"activeCount":52},[],{"trials":104,"activeCount":9,"soonestReadout":38},[105],{"nctId":36,"briefTitle":37,"status":64,"phases":106,"primaryCompletion":38,"completion":38,"start":66,"enrollment":67,"conditions":107,"interventions":108},[],[15,69,26],[39,71,72],{"intervention":110,"totalTrials":9,"cells":111},"botulinum toxin A",{"EARLY_PHASE1":112,"PHASE1":114,"PHASE2":116,"PHASE3":118,"PHASE4":120,"NA":132},{"trials":113,"activeCount":52},[],{"trials":115,"activeCount":52},[],{"trials":117,"activeCount":52},[],{"trials":119,"activeCount":52},[],{"trials":121,"activeCount":52},[122],{"nctId":123,"briefTitle":124,"status":125,"phases":126,"primaryCompletion":127,"completion":127,"start":128,"enrollment":129,"conditions":130,"interventions":131},"NCT00320281","Investigating Botulinum Toxin A to Treat Acute Neck\u002FUpper Shoulder Pain Following a New Spinal Cord Injury.","COMPLETED",[45],"2008-08","2006-04",19,[21,24],[110],{"trials":133,"activeCount":52},[],{"intervention":135,"totalTrials":9,"cells":136},"Androgel",{"EARLY_PHASE1":137,"PHASE1":139,"PHASE2":141,"PHASE3":143,"PHASE4":145,"NA":159},{"trials":138,"activeCount":52},[],{"trials":140,"activeCount":52},[],{"trials":142,"activeCount":52},[],{"trials":144,"activeCount":52},[],{"trials":146,"activeCount":52},[147],{"nctId":148,"briefTitle":149,"status":125,"phases":150,"primaryCompletion":151,"completion":151,"start":152,"enrollment":153,"conditions":154,"interventions":158},"NCT01201863","Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy",[45],"2014-07","2010-09",46,[155,156,157],"Endocrine Dysfunction","Trauma","Brain Injury",[135],{"trials":160,"activeCount":52},[],{"intervention":162,"totalTrials":9,"cells":163},"Simvastatin",{"EARLY_PHASE1":164,"PHASE1":166,"PHASE2":168,"PHASE3":181,"PHASE4":183,"NA":185},{"trials":165,"activeCount":52},[],{"trials":167,"activeCount":52},[],{"trials":169,"activeCount":52},[170],{"nctId":171,"briefTitle":172,"status":173,"phases":174,"primaryCompletion":175,"completion":176,"start":177,"enrollment":178,"conditions":179,"interventions":180},"NCT02946424","Simvastatin to Prevent SCI-Induced Bone Loss","UNKNOWN",[43],"2023-09","2023-09-30","2017-07-01",76,[15,28],[162],{"trials":182,"activeCount":52},[],{"trials":184,"activeCount":52},[],{"trials":186,"activeCount":52},[],{"intervention":188,"totalTrials":9,"cells":189},"Modafinil",{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":203,"PHASE3":205,"PHASE4":207,"NA":209},{"trials":191,"activeCount":52},[],{"trials":193,"activeCount":52},[194],{"nctId":195,"briefTitle":196,"status":125,"phases":197,"primaryCompletion":198,"completion":198,"start":199,"enrollment":67,"conditions":200,"interventions":202},"NCT00702637","Study of Modafinil to Treat Fatigue in Persons With Traumatic Brain Injury",[42],"2005-03","2002-10",[201],"Fatigue",[188],{"trials":204,"activeCount":52},[],{"trials":206,"activeCount":52},[],{"trials":208,"activeCount":52},[],{"trials":210,"activeCount":52},[],{"intervention":212,"totalTrials":9,"cells":213},"atomoxetine",{"EARLY_PHASE1":214,"PHASE1":216,"PHASE2":218,"PHASE3":220,"PHASE4":222,"NA":224},{"trials":215,"activeCount":52},[],{"trials":217,"activeCount":52},[],{"trials":219,"activeCount":52},[],{"trials":221,"activeCount":52},[],{"trials":223,"activeCount":52},[],{"trials":225,"activeCount":52},[226],{"nctId":227,"briefTitle":228,"status":125,"phases":229,"primaryCompletion":230,"completion":230,"start":231,"enrollment":67,"conditions":232,"interventions":234},"NCT00702364","Efficacy Study of Strattera for Treating Attention Disorders in Traumatic Brain Injury (TBI)",[46],"2012-03","2008-01",[233],"Traumatic Brain INjury",[212]]